..
..
..
The new allegations bring the total number of charges that Koh faces to 10, and the number of falsely vaccinated people named across her charges to seven.
..
Healing the Divide’s Iris Koh gets new charges of conspiring with doctor to lie about people being vaccinated
Published February 16, 2023
Updated February 16, 2023
SINGAPORE — Iris Koh Shu Cii, founder of the Healing the Divide group known to be against Covid-19 vaccination, has been handed more charges of conspiring to defraud the Ministry of Health (MOH).
Out of six charges, five are for conspiring with co-accused doctor Jipson Quah to lie to MOH that five people were vaccinated when they were not.
This allegedly occurred between October 2021 and December 2021. The five people who were allegedly falsely declared to be inoculated with the Sinopharm vaccine are: Goh Tua Buk, Bobby Teo, Steven Teo, Tan Kia Lee Carrie and Lee Amy.
The sixth charge is for instigating a woman, Tee Hui Yee, on Nov 5, 2021, to fabricate evidence and get her to be falsely certified to be of unsound mind.
It was intended that this would appear in evidence in a judicial proceeding, and cause the police to “entertain an erroneous opinion” on whether Quah had improperly administered Sinopharm vaccines of a lower dosage to patients, the charge read.
.
When she heard about the bail condition requiring her to not have any contact with the Healing the Divide group, Koh said: “There are 5,000 over members, it’s impossible for me.”
Judge Tay cut her off and told her to observe appropriate decorum.
..
..
..
..
..
..
*The study was only able to detect a correlation and could not prove that pioglitazone was reducing patients’ risk of dementia.
By Luke Andrews Health Reporter For Dailymail.Com
Updated: 21:25 GMT, 15 February 2023
A common type 2 diabetes drug may lower the risk of dementia, a study suggests.
Diabetes has long been linked to an increased risk of dementia, which is thought to be due to low blood sugar levels damaging areas of the brain, as well as diabetes’ link to high blood pressure.
Scientists in South Korea found an association between taking pioglitazone — sold under the brand name Actos — and lower rates of dementia for type 2 diabetics.
The study tracked 91,000 adults in their 60s, including 3,500 who took the drug, over 10 years. The longer patients had been taking the drug, the lower their risk of dementia.
Those on the drug for more than four years appeared to be 37 percent less likely to be diagnosed with the condition.
The study was only able to detect a correlation and could not prove that pioglitazone was reducing patients’ risk of dementia.
Pioglitazone is available on prescription for type 2 diabetes patients.
It is prescribed to around 3million Americans and more than a million Britons every year.
Past studies have also linked the drug with a reduced risk of dementia and even suggested it can help to prevent hospitalization and death from Covid.
Pioglitazone has been available since 1985.
https://www.dailymail.co.uk/health/article-11754493/Diabetes-drug-lower-risk-DEMENTIA-study-suggests.html?ito=social-twitter_dailymailus&ito=social-twitter_mailonline
..